Pharma Educación
Calificación, Validación
Equipos y Servicios Técnicos
Cel y Whatsapp:
722 57 27 020
info@pharma-education.com.mx
Noticias FDA
Antifungal Susceptibility Test Interpretive Criteria
(mar, 01 abr 2025)
Antifungal Susceptibility Test Interpretive Criteria
>> Leer más
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) (Tue, 01 Apr 2025)
Learn about the FDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) designed to curb opioid misuse by ensuring safe prescribing, dispensing, and patient monitoring practices. This initiative targets healthcare professionals and aims to improve patient safety and opioid education.
>> Leer más
Antifungal Susceptibility Test Interpretive Criteria
>> Leer más
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) (Tue, 01 Apr 2025)
Learn about the FDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) designed to curb opioid misuse by ensuring safe prescribing, dispensing, and patient monitoring practices. This initiative targets healthcare professionals and aims to improve patient safety and opioid education.
>> Leer más